期刊文献+

洛伐他汀联合厄贝沙坦对梗阻性肾病大鼠骨桥蛋白及肾间质纤维化的影响 被引量:1

Effect of union treatment of lovastatin and irbesartan on osteopontin expression and tubulointerstitial fibrosis in obstructive nephropathy rats
下载PDF
导出
摘要 目的探讨洛伐他汀联合厄贝沙坦对单侧输尿管梗阻大鼠骨桥蛋白(OPN)表达及肾间质纤维化的影响。方法将试验用SD大鼠随机分为4组(n=10):假手术对照组、单侧输尿管结扎组(UUO组)、厄贝沙坦组(60mg/L)、联合治疗组(洛伐他汀20mg/L联合厄贝沙坦60mg/L)。对照组及模型组仅予等量生理盐水灌胃。观察各组大鼠第6周肾功能、24h尿蛋白和肾组织病理学改变,并检测肾组织骨桥蛋白的表达。结果与模型组比较,厄贝沙坦治疗能使OPN的表达降低(P<0.05),使24h尿蛋白及血清肌酐(Scr)降低(P<0.05),肾组织病理损害减轻,肾小管间质面积较模型组显著减少(P<0.01);而洛伐他汀联合厄贝沙坦治疗后,OPN的表达降低更为显著,肾功能及肾组织病理损害改善更为明显。结论洛伐他汀联合厄贝沙坦可明显降低单侧输尿管梗阻大鼠肾小管间质OPN的表达,减轻肾小管间质纤维化而发挥肾脏保护作用。 Objective To investigate the effects of union treatment of lovastatin and irbesartan on the expression of osteopontin (OPN) and renal tubulointerstitial fibrosis. Methods Experimental SD rats were randomly divided into four groups (n = 10) respectively:sham operation group,unilateral ureteral ligation operation group (UUO group),irbesartan group (60 mg/L) and combination group (with 20 mg/L lovastatin combined 60 mg/L irbesartan).The rats in sham operation group and UUO group were treated with equal normal saline.After 6 weeks,observing renal function,histopathological changes and 24-hours proteinuria,and detecting the expression of OPN in renal interstitium. Results Irbesartan treatment could reduce the expression of OPN compared with model group ( P 0.05),24 h urinary albumin and serum creatinine (Scr) decreased (P 0.05) and alleviate the damages of renal histopathology,renal tubular interstitial area was significantly reduced in the model group (P 0.01);And lovastatin combined irbesartan treatment,the expression of OPN reduced more significantly,renal function and kidney pathology damage improvement was more obvious. Conclusion By the combined treatment of lovastatin and irbesartan,the expression of OPN is significantly decreased and renal interstitial fibrosis is obviously ameliorated in obstructive nephropathy rats.
出处 《中国当代医药》 2013年第18期9-11,共3页 China Modern Medicine
基金 贵州省国际科技合作计划项目(黔科合外G字[2012]7045号) 贵州省科学技术基金项目(黔科合J字[2010]2173号) 贵州省优秀科技教育人才省长专项资金项目(黔省专合字[2010]89号)
关键词 洛伐他汀 厄贝沙坦 骨桥蛋白 肾间质纤维化 Lovastatin Irbesartan Osteopontin Tubulointerstitial fibrosis
  • 相关文献

参考文献4

二级参考文献38

  • 1黄海长,于迎,梁燕,闵亚丽,胡昭,陈敏,李惊子,王海燕.低氧刺激结缔组织生长因子表达与肾间质纤维化[J].中国病理生理杂志,2005,21(3):432-435. 被引量:15
  • 2Chong PH,Seeger JD,Franklin C.Clinically relevant differences between the statins:implications for therapeutic.Am J Med,2001,111,390~40
  • 3Kim SI,Han DC,Lee HB.Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells.J Am Soc Nephrol,2000,11,80~87
  • 4Jandeleit-Dahm K,Cao Z,Cox AJ,et al.Role of hyperlipidemia in progressive renal disease:focus on diabetic nephropathy.Kidney Int 1999,56(Suppl 71),S31~64
  • 5Park JK,Muller DN,Mervaala EM.Cerivastatin prevents angiotensin Ⅱ-induced renal injury independent of blood pressure-and cholesterol-lowering effects.Kidney Int,2000,58(4),1420~1430
  • 6Yokota N,O'Donnell M,Daniels F,et al.Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury.Am J Nephrol,2003,23(1),13~7
  • 7O'Donnell MP,Kasiske BL,Kim Y,et al.Lovastatin retards the progression of established glomerular disease in obese Zucker rats.Am J Kidney Dis,1993,22,83~89
  • 8Yoshimura A,Inui K,Nemoto T,et al.Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.J Am Soc Nephrol,1998,9,2027~2039
  • 9Zoja C,Corna D,Rottoli D,et al.Effect of combining ACE inhibitor and statin in severe experimental.Kidney Int,2002,61(5),1635~45
  • 10Danesh FR,Sadeghi MM,Amro N,et al.3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/P21 signaling pathway. Pro Natl Acad Sci USA,2002,99(12),8301~5

共引文献52

同被引文献18

  • 1王丽晖,段惠军,史永红,刘青娟,何宁,刘淑霞.洛伐他汀对糖尿病大鼠肾功能及肾脏组织p38丝裂原激活蛋白激酶表达的影响[J].中国危重病急救医学,2004,16(12):734-737. 被引量:5
  • 2Dai H Y,Zheng M,Lv L L,et al.The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes[J].J Cell Biochem,2012,113(1):293-301.
  • 3Fang Y,Tian X,Bai S,et al.Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress,pro-inflammatory cytokines and the p38 MAPK signaling pathway[J].Int J Mol Med,2012,30(1):85-92.
  • 4Gao P,Wu X,Shui H,et al.Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells[J].J Nephrol,2013,26(2):289-296.
  • 5Fang D,Guan H,Liu J,et al.Early intensive insulin therapy attenuates the p38 pathway in the renal cortex and indices of nephropathy in diabetic rats[J].Endocr J,2012,59(1):81-90.
  • 6Usui H,Shikata K,Matsuda M,et al.HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats[J].Nephrol Dial Transplant,2003,18(2):265-272.
  • 7Song Y,Li C,Cai L.Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation[J].Exp Mol Pathol,2004,76(1):66-75.
  • 8Tossidou I,Starker G,Kruger J,et al.PKC-alpha modulates TGF-beta signaling impairs podocyte survival[J].Cell Physiol Biochem,2009,24(5-6):627-634.
  • 9Kim S I,Han D C,Lee H B,et al.Lovastatin inhibits transforming growth factor-beta 1 expression in diabetic rat glomeruli and cultured rat mesangial cells[J].J Am Soc Nephrol,2000,11(1):80-87.
  • 10Tall E G,Bernstein A M,Oliver N.TGF-β-stimulated CTGF production enhanced by collagen and associated with biogenesis of a novel 31kDa CTGF form in human corneal fibroblasts[J].Invest Ophthamlol Vis Sci,2010,51(10):5002-5011.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部